Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer.
Yang HW, Lan Y, Li A, Wu H, Song ZW, Wan AL, Wang Y, Li SB, Ji S, Wang ZC, Wu XY, Lan T.
Yang HW, et al. Among authors: wu h, wu xy.
Front Pharmacol. 2023 Nov 9;14:1288883. doi: 10.3389/fphar.2023.1288883. eCollection 2023.
Front Pharmacol. 2023.
PMID: 38026996
Free PMC article.